Peptide Shuttle-Mediated Delivery for Brain Gene Therapies

Author(s): Josep Garcia, Pol Arranz-Gibert, Macarena Sánchez-Navarro, Ernest Giralt, Meritxell Teixidó*

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 32 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The manipulation of an individual’s genetic information to treat a disease has revolutionized the biomedicine field. Despite the promise of gene therapy, this treatment can have long-term sideeffects. Efforts in the field and recent discoveries have already led to several improvements, including efficient gene delivery and transfer, as well as inpatient safety. Several studies to treat a wide range of pathologies-such as cancer or monogenic diseases- are currently being conducted. Here we provide a broad overview of methodologies available for gene therapy, placing a strong emphasis on treatments for central nervous system diseases. Finally, we give a perspective on current delivery strategies to treat such diseases, with a special focus on systems that use peptides as delivery vectors.

Keywords: Gene therapy, Genome editing, CRISPR, Viral vectors, Nanoparticles, Central nervous system, Drug delivery, Peptide shuttles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 03 December, 2020
Page: [2945 - 2958]
Pages: 14
DOI: 10.2174/1568026620666201023122903
Price: $65

Article Metrics

PDF: 30